Hms Capital Management, LLC Pfizer Inc Transaction History

Hms Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$46.53 - $55.17 $223,204 - $264,650	4,797 New	4,797 $252,000
Q3 2019 Oct 15, 2019	SELL	$32.49 - $42.13 $53,283 - $69,093	-1,640 Closed	0 $0
Q2 2019 Jul 12, 2019	BUY	$36.98 - $41.52 $60,647 - $68,092	1,640 New	1,640 $71,000
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $175,423 - $200,001	-4,560 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $157,183 - $190,653	4,560 New	4,560 $201,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Hms Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Hms Capital Management, LLC with notifications on news.